TWD 46.3
(-1.38%)
Year | Net Income | Net Income Growth |
---|---|---|
2023 | 143.94 Million TWD | 146.31% |
2022 | -310.8 Million TWD | -358.63% |
2021 | 120.17 Million TWD | -39.7% |
2020 | 199.3 Million TWD | -19.53% |
2019 | 247.66 Million TWD | 0.0% |
Year | Net Income | Net Income Growth |
---|---|---|
2024 Q2 | -70.54 Million TWD | 21.49% |
2024 Q1 | -89.85 Million TWD | -126.43% |
2023 Q4 | 339.93 Million TWD | 1077.76% |
2023 FY | 143.94 Million TWD | 146.31% |
2023 Q3 | -34.76 Million TWD | 81.61% |
2023 Q2 | -189.03 Million TWD | -779.92% |
2023 Q1 | 27.8 Million TWD | 156.06% |
2022 Q4 | -49.59 Million TWD | 0.0% |
2022 FY | -310.8 Million TWD | -358.63% |
2021 FY | 120.17 Million TWD | -39.7% |
2020 FY | 199.3 Million TWD | 0.0% |
Name | Net Income | Net Income Difference |
---|---|---|
Allied Biotech Corporation | 97.41 Million TWD | -47.767% |
GeneFerm Biotechnology Co., Ltd. | 124.62 Million TWD | -15.505% |
Easywell Biomedicals, Inc. | -144.81 Million TWD | 199.396% |
TTY Biopharm Company Limited | 1.12 Billion TWD | 87.245% |
Synmosa Biopharma Corporation | 594.83 Million TWD | 75.801% |
Center Laboratories, Inc. | -995.42 Million TWD | 114.461% |
Tien Liang BioTech Co., Ltd. | 17.73 Million TWD | -711.77% |
Orient Pharma Co., Ltd. | 22.28 Million TWD | -545.832% |
InnoPharmax Inc. | -70.83 Million TWD | 303.22% |
Johnson Chemical Pharmaceutical Works Co., Ltd. | 79.7 Million TWD | -80.606% |
Excelsior Biopharma Inc. | -91.01 Million TWD | 258.16% |
DV Biomed Co., Ltd. | 162.91 Million TWD | 11.643% |
Foresee Pharmaceuticals Co., Ltd. | -1.03 Billion TWD | 113.89% |
Handa Pharmaceuticals, Inc. | 726.88 Million TWD | 80.197% |
UniPharma Co., Ltd. | -21.81 Million TWD | 759.895% |
Anxo Pharmaceutical Co., Ltd. | 21.86 Million TWD | -558.447% |
Alar Pharmaceuticals Inc. | 382.61 Million TWD | 62.379% |
Winston Medical Supply Co., Ltd. | 158.75 Million TWD | 9.33% |
Mercury Biopharmaceutical Corporation | -43.81 Million TWD | 428.517% |
Bioray Biotech Co., Ltd | -11.55 Million TWD | 1345.289% |
TSH Biopharm Corporation Limited | 61.98 Million TWD | -132.207% |